<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39308538</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2008-2258</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Gastroenterology and hepatology from bed to bench</Title><ISOAbbreviation>Gastroenterol Hepatol Bed Bench</ISOAbbreviation></Journal><ArticleTitle>Comparing the effectiveness of online individualized transdiagnostic treatment with acceptance and commitment therapy on medication adherence, gastrointestinal symptoms and perceived stress of patients with irritable bowel syndrome.</ArticleTitle><Pagination><StartPage>288</StartPage><EndPage>296</EndPage><MedlinePgn>288-296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22037/ghfbb.v17i3.2920</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="UNASSIGNED">This study aimed to investigate whether transdiagnostic treatment as well as acceptance and commitment therapy (ACT) could improve treatment adherence and alleviate gastrointestinal symptoms plus perceived stress in patients suffering from irritable bowel syndrome.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Research has shown that people with chronic diseases often have negative attitudes toward medications, especially when they also have psychiatric disorders. This, along with the complex dosing requirements and inadequate knowledge about medication adherence among irritable bowel syndrome patients, can affect the treatment efficacy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A randomized clinical trial was conducted using a pre-test-post-test design. The statistical population included patients with irritable bowel syndrome referring to Taleghani Hospital in Tehran between winter 2021 and spring 2022. Convenience sampling was used to select 30 individuals, with 15 people assigned to each group. Two types of psychotherapy were provided online and individually to the participants. The desired treatments were given to the transdiagnostic treatment and ACT groups in eight weekly sessions of 45-60 minutes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There was no significant difference between the transdiagnostic treatment pre-test and ACT regarding perceived stress, medication adherence, and gastrointestinal symptoms (P&gt;0.05). There was no significant difference either between the transdiagnostic treatment and ACT post-test. However, there was a significant difference between the pre-test and post-test phases of ACT regarding adherence, gastrointestinal symptoms, plus perceived stress (P&lt;0.05) and transdiagnostic treatment regarding gastrointestinal symptoms (P&lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Specialists may use transdiagnostic treatment and ACT as effective psychological treatments to alleviate gastrointestinal symptoms and perceived stress, thereby increasing treatment adherence in patients with irritable bowel syndrome.</AbstractText><CopyrightInformation>&#xa9; 2024, Gastroenterology and Hepatology From Bed to Bench (GHFBB).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shahkaram</LastName><ForeName>Homa</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeghi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masjedi Arani</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakhtiari</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kianimoghadam</LastName><ForeName>Amir Sam</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Clinical Psychology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Gastroenterol Hepatol Bed Bench</MedlineTA><NlmUniqueID>101525875</NlmUniqueID><ISSNLinking>2008-2258</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acceptance and commitment therapy</Keyword><Keyword MajorTopicYN="N">Irritable bowel syndrome</Keyword><Keyword MajorTopicYN="N">Medication adherence</Keyword><Keyword MajorTopicYN="N">Physiological</Keyword><Keyword MajorTopicYN="N">Stress</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39308538</ArticleId><ArticleId IdType="pmc">PMC11413384</ArticleId><ArticleId IdType="doi">10.22037/ghfbb.v17i3.2920</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Black CJ, Drossman DA, Talley NJ, Ruddy J, Ford AC. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2020;396:1664&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">33049221</ArticleId></ArticleIdList></Reference><Reference><Citation>Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">25734736</ArticleId></ArticleIdList></Reference><Reference><Citation>Coward S, Benchimol EI, Kuenzig ME, Windsor JW, Bernstein CN, Bitton A, et al. The 2023 impact of inflammatory bowel disease in Canada: epidemiology of IBD. J Can Assoc Gastroenterol. 2023;6:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10478802</ArticleId><ArticleId IdType="pubmed">37674492</ArticleId></ArticleIdList></Reference><Reference><Citation>Szigethy E, Murphy SM, Ehrlich OG, Engel-Nitz NM, Heller CA, Henrichsen K, et al. Mental health costs of inflammatory bowel diseases. Inflamm Bowel Dis. 2021;27:40&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32095835</ArticleId></ArticleIdList></Reference><Reference><Citation>Treynor W, Gonzalez R, Nolen-Hoeksema S. Rumination reconsidered: A psychometric analysis. Cognitive Ther Res. 2003;27:247&#x2013;59.</Citation></Reference><Reference><Citation>Borowitz SM. The epidemiology of inflammatory bowel disease: Clues to pathogenesis? Front Pediatr. 2022;10:1103713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886670</ArticleId><ArticleId IdType="pubmed">36733765</ArticleId></ArticleIdList></Reference><Reference><Citation>Weaver KR, Melkus GD, Fletcher J, Henderson WA. Perceived stress, its physiological correlates, and quality of life in patients with irritable bowel syndrome. Biol Res Nurs. 2018;20:312&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5993079</ArticleId><ArticleId IdType="pubmed">29402137</ArticleId></ArticleIdList></Reference><Reference><Citation>Targownik LE, Sexton KA, Bernstein MT, Beatie B, Sargent M, Walker JR, Graff LA. The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease. Am J Gastroenterol. 2015;110:1001&#x2013;12; quiz 13.</Citation><ArticleIdList><ArticleId IdType="pubmed">26077178</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein CN, Singh S, Graff LA, Walker JR, Miller N, Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol. 2010;105:1994&#x2013;2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">20372115</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Peng P, Ding N, Jia W, Huang C, Tang Y. Oxidative stress, inflammation, gut dysbiosis: what can polyphenols do in inflammatory bowel disease? Antioxidants. 2023;12:967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10135842</ArticleId><ArticleId IdType="pubmed">37107341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash BD, Pimentel M, Rao SS, Weinstock L, Chang L, Heimanson Z, Lembo A. Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therap Adv Gastroenterol. 2017;10:689&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5598815</ArticleId><ArticleId IdType="pubmed">28932270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassell B, Gyawali PC, Kushnir VM, Gott BM, Nix BD, Sayuk GS. Beliefs about GI medications and adherence to pharmacotherapy in functional GI disorder outpatients. ACG. 2015;110:1382&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051635</ArticleId><ArticleId IdType="pubmed">25916226</ArticleId></ArticleIdList></Reference><Reference><Citation>Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934668</ArticleId><ArticleId IdType="pubmed">24591853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwin LB, Deroche CB, Krisanabud P, Matteson-Kome M, Bechtold M, Ruppar T. Adherence to short-course pharmacotherapy in adults with irritable bowel syndrome. West J Nurs Res. 2020;42:524&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">31441709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi R, Mehrotra S. Irritable bowel syndrome and its psychological management. Ind Psychiatry J. 2015;24:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4525441</ArticleId><ArticleId IdType="pubmed">26257492</ArticleId></ArticleIdList></Reference><Reference><Citation>Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012;43:666&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383087</ArticleId><ArticleId IdType="pubmed">22697453</ArticleId></ArticleIdList></Reference><Reference><Citation>Abasi I, Fata L, Sadeghi M, Banihashemi S, Mohammadee A. A comparison of transdiagnostic components in generalized anxiety disorder, unipolar mood disorder and nonclinical population. Int J Psychol Sci. 2013;7:803&#x2013;11.</Citation></Reference><Reference><Citation>Benuto LT, Farchione T, Cardona ND, Segovia FR, Casas J, Reyes SR. Exploring the effectiveness of the unified protocol for transdiagnostic treatment of emotional disorders with latinxs: a record-review study at a culturally specific clinic for latinxs. Cogn Behav Pract . 2023</Citation></Reference><Reference><Citation>Bravo Ferreira N, Eugenicos M, Graham Morris P, Gillanders D. Using acceptance and commitment therapy in irritable bowel syndrome. Gastrointestinal Nursing. 2011;9:28&#x2013;35.</Citation></Reference><Reference><Citation>Hayes SC, Pistorello J, Levin ME. Acceptance and commitment therapy as a unified model of behavior change. Counseling Psychologist. 2012;40:976&#x2013;1002.</Citation></Reference><Reference><Citation>Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy. American Psychological Association; 1999.</Citation></Reference><Reference><Citation>Mohsenabadi H, Zanjani Z, Shabani MJ, Arj A. A randomized clinical trial of the Unified Protocol for Transdiagnostic treatment of emotional and gastrointestinal symptoms in patients with irritable bowel syndrome: evaluating efficacy and mechanism of change. J Psychosom Res. 2018;113:8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlow DH, Ellard KK, Fairholme CP. Unified protocol for transdiagnostic treatment of emotional disorders: Workbook. Oxford University Press; 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7986982</ArticleId><ArticleId IdType="pubmed">33762811</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisi S, Ahmadi SM, Foroughi A, Bahrami R, Parvizifard A. Transdiagnostic therapy compared to progressive muscle relaxation on the emotional health of mothers with premature infants: A randomized controlled trial. Int J Psychiatry Med. 2024;59:112&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">37216682</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh-Mirkohan RA, Taklavi S, Kazemi R. Comparing the effectiveness of acceptance and commitment therapy with mindfulness based cognitive therapy, on self-control and emotional flexibility in women with compulsive buying. Rooyesh-e-Ravanshenasi Journal. 2021;10:13&#x2013;24.</Citation></Reference><Reference><Citation>Safaei H. Assessing Stress in Cancer Patients: Factorial Validity of the Perceived Stress Scale in Iran. IJPN. 2014;2:13&#x2013;22.</Citation></Reference><Reference><Citation>Cohen S, Kamarck T, Mermelstein R. Perceived stress scale. Measuring stress: A guide for health and social scientists. 1994;10:1&#x2013;2.</Citation></Reference><Reference><Citation>Kulich KR, Madisch A, Pacini F, Piqu&#xe9; JM, Regula J, Van Rensburg CJ, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (GSRS) and Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2276197</ArticleId><ArticleId IdType="pubmed">18237386</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazaheri M, SadatKhoshouei M. Comparison between psychometric characteristics of Persian version of the gastrointestinal symptoms rating scale in functional gastrointestinal disorders and normal groups. Govaresh. 2012;17:18&#x2013;24.</Citation></Reference><Reference><Citation>Moharamzad Y, Saadat H, Shahraki BN, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item Morisky Medication Adherence Scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7:173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4802120</ArticleId><ArticleId IdType="pubmed">25946926</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon SJ, Lee WY, Hwang JS, Hong YP, Morisky DE. Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One. 2017;12:0187139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5667769</ArticleId><ArticleId IdType="pubmed">29095870</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SP, Sung IK, Kim JH, Lee SY, Park HS, Shim CS. The effect of emotional stress and depression on the prevalence of digestive diseases. J Neurogastroenterol Motil. 2015;21:273&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4398234</ArticleId><ArticleId IdType="pubmed">25779692</ArticleId></ArticleIdList></Reference><Reference><Citation>Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011;62:591&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22314561</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20:14126&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4202343</ArticleId><ArticleId IdType="pubmed">25339801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol. 2011;106:1678&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6502251</ArticleId><ArticleId IdType="pubmed">21691341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M, Son C. Effects of acceptance and commitment therapy (ACT) on IBS-symptoms, stress, quality of life, and acceptance-action of people with irritable bowel syndrome. J Digit Converg. 2018;16:501&#x2013;9.</Citation></Reference><Reference><Citation>DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23:207&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">15008666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissane D. Beyond the psychotherapy and survival debate: the challenge of social disparity, depression and treatment adherence in psychosocial cancer care. Psychooncology. 2009;18:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19097139</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro A, Gili M, Ricci-Cabello I, Roca M, Gilbody S, Perez-Ara MA, et al. Effectiveness and adherence of telephone-administered psychotherapy for depression: A systematic review and meta-analysis. J Affect Disord. 2020;260:514&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">31539688</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold SM, Kohler-Forsberg O, Moss-Morris R, Mehnert A, Miranda JJ, Bullinger M, et al. Comorbid depression in medical diseases. Nat Rev Dis Primers. 2020;6:69.</Citation><ArticleIdList><ArticleId IdType="pubmed">32820163</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrdoljak J, Vilovic M, Zivkovic PM, Tadin Hadjina I, Rusic D, Bukic J, et al. Mediterranean Diet Adherence and Dietary Attitudes in Patients with Inflammatory Bowel Disease. Nutrients. 2020;12:3429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695291</ArticleId><ArticleId IdType="pubmed">33171662</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabat&#xe9; E. Adherence to long-term therapies: evidence for action. World Health Organization; 2003.</Citation></Reference><Reference><Citation>Jackson C, Clatworthy J, Robinson A, Horne R. Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. ACG. 2010;105:525&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">19997092</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res. 2017;15:434&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683974</ArticleId><ArticleId IdType="pubmed">29142511</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenley RN, Gumidyala AP, Nguyen E, Plevinsky JM, Poulopoulos N, Thomason MM, et al. Can you teach a teen new tricks? Problem solving skills training improves oral medication adherence in pediatric patients with inflammatory bowel disease participating in a randomized trial. Inflamm Bowel Dis. 2015;21:2649&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">26218142</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook PF, Emiliozzi S, El-Hajj D, McCabe MM. Telephone nurse counseling for medication adherence in ulcerative colitis: a preliminary study. Patient Educ Couns. 2010;81:182&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20079598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2012;24:64&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3233635</ArticleId><ArticleId IdType="pubmed">21989119</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshkovska T, Stone MA, Smith RM, Bankart J, Baker R, Mayberry JF. Impact of a tailored patient preference intervention in adherence to 5-aminosalicylic acid medication in ulcerative colitis: results from an exploratory randomized controlled trial. Inflamm Bowel Dis. 2011;17:1874&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830265</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkjaer M, Shuhaibar M, Burisch J, Bailey Y, Scherfig H, Laugesen B, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach. Gut. 2010;59:1652&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">21071584</ArticleId></ArticleIdList></Reference><Reference><Citation>von Wietersheim J, Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis. 2006;12:1175&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">17119392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>